Osteoporosis: The New Field for Dx/Rx Collaboration
Pharmaceutical-diagnostic company alliances have had mixed results in the past, but both sides have greater incentives to work through differences. Nowhere is this more apparent than in the burgeoning field of osteoporosis disease management.
You may also be interested in...
Confidence in the vaccine has slipped in the US, regardless of political affiliation.
Can "real world evidence" drive consumer health innovation? HBW Insight speaks to Orbital Research’s Chris Bunniss about RWE’s potential for the OTC industry.
Italy's Chiesi is looking to take a slice of Poland's consumer healthcare market by acquiring infant supplements specialist Smart Pharma.